• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up.

作者信息

Lupo-Stanghellini Maria Teresa, Piemontese Simona, Assanelli Andrea, Serpenti Fabio, Mastaglio Sara, Clerici Daniela, Giglio Fabio, Greco Raffaella, Lorentino Francesca, Pavesi Francesca, Farina Francesca, Marktel Sarah, Corti Consuelo, Peccatori Jacopo, Ciceri Fabio

机构信息

Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.

Vita-Salute San Raffaele University, Milano, Italy.

出版信息

Hemasphere. 2021 Oct 28;5(11):e654. doi: 10.1097/HS9.0000000000000654. eCollection 2021 Nov.

DOI:10.1097/HS9.0000000000000654
PMID:34901758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8659994/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e8/8659994/c84531cb1857/hs9-5-e654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e8/8659994/c84531cb1857/hs9-5-e654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e8/8659994/c84531cb1857/hs9-5-e654-g001.jpg

相似文献

1
Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up.造血干细胞移植后的第二种实体癌：长期随访期间的主动监测
Hemasphere. 2021 Oct 28;5(11):e654. doi: 10.1097/HS9.0000000000000654. eCollection 2021 Nov.
2
Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.成人异基因造血干细胞移植后慢性移植物抗宿主病与口腔/食管癌风险持续增加相关。
Ann Oncol. 2014 Feb;25(2):435-41. doi: 10.1093/annonc/mdt558. Epub 2014 Jan 7.
3
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.异基因造血干细胞移植后实体瘤中程序性死亡配体 1（PD-L1）：长崎移植组的回顾性分析。
Int J Hematol. 2020 Oct;112(4):524-534. doi: 10.1007/s12185-020-02926-6. Epub 2020 Jun 25.
4
Second Malignancies after Hematopoietic Stem Cell Transplantation.造血干细胞移植后的第二恶性肿瘤。
Curr Treat Options Oncol. 2018 Feb 8;19(2):9. doi: 10.1007/s11864-018-0528-y.
5
Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.异基因造血干细胞移植后继发性实体恶性肿瘤的风险及预防策略。
Future Oncol. 2015;11(23):3175-85. doi: 10.2217/fon.15.252. Epub 2015 Nov 9.
6
Second solid cancers after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后的第二种实体癌。
Cancer. 2007 Jan 1;109(1):84-92. doi: 10.1002/cncr.22375.
7
[Subsequent malignancies after long-term follow-up of pediatric hematopoietic stem cell transplantation].[儿童造血干细胞移植长期随访后的后续恶性肿瘤]
An Pediatr (Engl Ed). 2019 Mar;90(3):157-164. doi: 10.1016/j.anpedi.2018.05.023. Epub 2018 Sep 5.
8
Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.欧洲患者造血干细胞移植后第二实体瘤的评估。
JAMA Oncol. 2019 Feb 1;5(2):229-235. doi: 10.1001/jamaoncol.2018.4934.
9
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.异基因造血细胞移植后使用白消安-环磷酰胺预处理的继发实体瘤。
Blood. 2011 Jan 6;117(1):316-22. doi: 10.1182/blood-2010-07-294629. Epub 2010 Oct 6.
10
Hunter syndrome (Mucopolysaccharidosis type II), severe phenotype: long term follow-up on patients undergone to hematopoietic stem cell transplantation.亨特综合征（II型黏多糖贮积症），严重表型：接受造血干细胞移植患者的长期随访
Minerva Pediatr. 2013 Oct;65(5):487-96.

引用本文的文献

1
Mutation as a Distinct Feature of Myeloid Neoplasms in B-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis.B细胞非霍奇金淋巴瘤患者髓系肿瘤的独特特征——突变：一项回顾性分析
Cancers (Basel). 2025 Mar 31;17(7):1185. doi: 10.3390/cancers17071185.

本文引用的文献

1
Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.欧洲患者造血干细胞移植后第二实体瘤的评估。
JAMA Oncol. 2019 Feb 1;5(2):229-235. doi: 10.1001/jamaoncol.2018.4934.
2
Late effects of blood and marrow transplantation.血液和骨髓移植的远期效应。
Haematologica. 2017 Apr;102(4):614-625. doi: 10.3324/haematol.2016.150250. Epub 2017 Feb 23.
3
Secondary solid cancer screening following hematopoietic cell transplantation.造血细胞移植后的继发性实体癌筛查。
Bone Marrow Transplant. 2015 Aug;50(8):1013-23. doi: 10.1038/bmt.2015.63. Epub 2015 Mar 30.
4
Caring for the long-term survivor after allogeneic stem cell transplantation.异基因造血干细胞移植后长期存活者的护理
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):495-503. doi: 10.1182/asheducation-2014.1.495. Epub 2014 Nov 18.
5
Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.迷失在过渡阶段：血液和骨髓移植幸存者长期随访诊所的迫切需求
Biol Blood Marrow Transplant. 2015 Feb;21(2):225-32. doi: 10.1016/j.bbmt.2014.06.035. Epub 2014 Jul 3.
6
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.造血细胞移植后长期生存者的推荐筛查和预防措施。
Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71. doi: 10.1016/j.bbmt.2011.12.519. Epub 2011 Dec 13.
7
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.存在竞争风险时失败概率的估计：旧估计量的新表示形式。
Stat Med. 1999 Mar 30;18(6):695-706. doi: 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o.